G. Mak

发表

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

D. Phelan, P. Collier, C. Watson, 2011, European journal of heart failure.

Anemia in heart failure: To treat or not to treat?

K. McDonald, G. Mak, N. Murphy, 2008, Current treatment options in cardiovascular medicine.

Diagnosis of new onset heart failure in the community: the importance of a shared-care approach and judicious use of BNP

C. O’loughlin, K. McDonald, G. Mak, 2008, Irish journal of medical science.

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

D. Phelan, C. Watson, K. McDonald, 2009, Journal of the American College of Cardiology.

Differentiating heart failure phenotypes using sex‐specific transcriptomic and proteomic biomarker panels

B. McManus, R. Ng, J. Dyck, 2017, ESC heart failure.

Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

C. O’loughlin, K. McDonald, G. Mak, 2008, Journal of cardiac failure.

Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study.

J. Leipsic, D. Wood, F. Neumann, 2016, JACC. Cardiovascular interventions.

Mitral Annular Dimensions and Geometry in Patients With Functional Mitral Regurgitation and Mitral Valve Prolapse: Implications for Transcatheter Mitral Valve Implantation.

J. Leipsic, P. Blanke, A. Cheung, 2016, JACC. Cardiovascular imaging.

Three-Dimensional Echocardiography Compared With Computed Tomography to Determine Mitral Annulus Size Before Transcatheter Mitral Valve Implantation

J. Leipsic, P. Blanke, R. Boone, 2016, Circulation. Cardiovascular imaging.